PathXL, a Belfast-based company which is developing pioneering digital pathology technology, plans to invest £3.6 million and create 32 new jobs over the next three years. The Queen's University spin ...
At Health First, this innovation is being brought to life through partners like NextGen Pathology, delivering precise diagnostic services.
Digital pathology company Deciphex has closed an $11.5 million (€10.9 million) Series B funding round. The Irish company develops software and artificial intelligence to accelerate the delivery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback